S0230-500, Bovine Serum (USA Origin) - 500ml

S0230-500, Bovine Serum (USA Origin) - 500ml

ECV001-48T, Human SARS-CoV-2 Nucleocapsid ELISA Kit, 48T

ECV001-48T, Human SARS-CoV-2 Nucleocapsid ELISA Kit, 48T

P0867S, Boletopsis grisea Lectin (BGL) - 1 mg

1.677,90 RON

Boletopsis grisea Lectin (BGL) is a recombinant 15 kDa lectin from the Boletopsis grisea mushroom that has been expressed in E. coli.

SKU
NEB_P0867S

Product Information
Boletopsis grisea Lectin (BGL) is a recombinant 15 kDa lectin from the Boletopsis grisea mushroom that has been expressed in E. coli. BGL has two separately functioning ligand binding sites. Site 1 binds to O-glycans bearing the Tn antigen (GalNAc-α-Ser/Thr) or Thomsen-Friedenreich antigen (TF-antigen; Gal-β1,3-GalNAc-α-) and Site 2 binds N-glycans with terminal GlcNAc residues.

Binds to N-glycans having at least one terminal outer arm GlcNAc as well as O-glycans containing Gal-β1,3-GalNAc-α- within their structure.
Enables enrichment of GlcNAc-capped N-glycans or mucin type O-glycopeptides from complex samples in glycomics and glycoproteomics analytical workflows.
This is an Enzyme for Innovation (EFI). EFI is a project initiated by NEB to provide unique enzymes to the scientific community in the hopes of enabling the discovery of new and innovative applications. These enzymes have interesting properties and unique specificities.

Mai multe informatii

Mai multe informatii
Price 1.410,00 RON (preturile sunt fara TVA)
Description

Product Information
Boletopsis grisea Lectin (BGL) is a recombinant 15 kDa lectin from the Boletopsis grisea mushroom that has been expressed in E. coli. BGL has two separately functioning ligand binding sites. Site 1 binds to O-glycans bearing the Tn antigen (GalNAc-α-Ser/Thr) or Thomsen-Friedenreich antigen (TF-antigen; Gal-β1,3-GalNAc-α-) and Site 2 binds N-glycans with terminal GlcNAc residues.

Binds to N-glycans having at least one terminal outer arm GlcNAc as well as O-glycans containing Gal-β1,3-GalNAc-α- within their structure.
Enables enrichment of GlcNAc-capped N-glycans or mucin type O-glycopeptides from complex samples in glycomics and glycoproteomics analytical workflows.
This is an Enzyme for Innovation (EFI). EFI is a project initiated by NEB to provide unique enzymes to the scientific community in the hopes of enabling the discovery of new and innovative applications. These enzymes have interesting properties and unique specificities.